Consolidated Planning Corp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$736K Buy
2,814
+1,110
+65% +$285K 0.1% 95
2026
Q2
$429K Sell
1,704
-8
-0.5% -$1.72K 0.06% 106
2026
Q1
$372K Buy
1,712
+433
+34% +$96K 0.06% 107
2025
Q4
$292K Sell
1,279
-50
-4% -$11.4K 0.03% 177
2025
Q3
$308K Buy
1,329
+24
+2% +$4.89K 0.03% 163
2025
Q2
$242K Sell
1,305
-422
-24% -$78.4K 0.03% 172
2025
Q1
$362K Sell
1,727
-133
-7% -$25.9K 0.05% 145
2024
Q4
$331K Sell
1,860
-228
-11% -$41.9K 0.05% 158
2024
Q3
$412K Buy
2,088
+237
+13% +$44.2K 0.06% 136
2024
Q2
$317K Sell
1,851
-406
-18% -$67.3K 0.05% 137
2024
Q1
$411K Sell
2,257
-1,212
-35% -$209K 0.07% 115
2023
Q4
$538K Sell
3,469
-2,155
-38% -$314K 0.1% 104
2023
Q3
$838K Sell
5,624
-685
-11% -$101K 0.19% 92
2023
Q2
$850K Buy
+6,309
New +$925K 0.18% 96
2021
Q4
– Sell
-1,049
Closed -$113K – 65
2021
Q3
$113K Buy
+1,049
New +$120K 0.07% 91

Other funds holding ABBV

Consolidated Planning Corp's ABBV Position: Q3 2026 in Review

Consolidated Planning Corp increased its AbbVie (ABBV) stake by 65% in Q3 2026, buying an estimated $285K and bringing the position to 2,814 shares worth $736K. The position accounts for 0.1% of the portfolio, ranked #95.

Consolidated Planning Corp first reported a position in ABBV in Q3 2021 and has held it in 15 quarters since. The position peaked at $850K in Q2 2023. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Consolidated Planning Corp held 2,814 shares of AbbVie worth $736K as of Q3 2026.
  • Consolidated Planning Corp bought 1,110 AbbVie shares in Q3 2026, an estimated $285K.
  • AbbVie made up 0.1% of Consolidated Planning Corp's portfolio in Q3 2026, its #95 holding.
  • Consolidated Planning Corp first reported a position in AbbVie in Q3 2021 and has held it in 15 quarters since.
  • Consolidated Planning Corp's AbbVie position peaked at $850K in Q2 2023.
  • 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Consolidated Planning Corp's 13F filing for Q3 2026, filed 21 Oct 2026.